Morphic Holding Future Growth
Future criteria checks 2/6
Morphic Holding's earnings are forecast to decline at 8.7% per annum while its annual revenue is expected to grow at 76.5% per year. EPS is expected to decline by 2.4% per annum. Return on equity is forecast to be -71.2% in 3 years.
Key information
-8.7%
Earnings growth rate
-2.4%
EPS growth rate
Biotechs earnings growth | 25.1% |
Revenue growth rate | 76.5% |
Future return on equity | -71.2% |
Analyst coverage | Good |
Last updated | 26 Apr 2024 |
Recent future growth updates
Recent updates
We're Hopeful That Morphic Holding (NASDAQ:MORF) Will Use Its Cash Wisely
Jan 20Companies Like Morphic Holding (NASDAQ:MORF) Are In A Position To Invest In Growth
Sep 29We're Interested To See How Morphic Holding (NASDAQ:MORF) Uses Its Cash Hoard To Grow
Jun 07What Does The Future Hold For Morphic Holding, Inc. (NASDAQ:MORF)? These Analysts Have Been Cutting Their Estimates
Feb 15We're Hopeful That Morphic Holding (NASDAQ:MORF) Will Use Its Cash Wisely
Jan 03What Does The Future Hold For Morphic Holding, Inc. (NASDAQ:MORF)? These Analysts Have Been Cutting Their Estimates
Nov 08Morphic GAAP EPS of -$0.68 beats by $0.17, revenue of $60.2M
Aug 03Revenue Downgrade: Here's What Analysts Forecast For Morphic Holding, Inc. (NASDAQ:MORF)
May 06Analyst Forecasts Just Became More Bearish On Morphic Holding, Inc. (NASDAQ:MORF)
Mar 01Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation
Feb 17We're Not Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn
Nov 03Morphic: Pioneering Integrin Medicines
Oct 13Morphic Holding (NASDAQ:MORF) Is In A Strong Position To Grow Its Business
Aug 05Companies Like Morphic Holding (NASDAQ:MORF) Can Afford To Invest In Growth
Apr 05Independent Director Vikas Goyal Just Bought A Handful Of Shares In Morphic Holding, Inc. (NASDAQ:MORF)
Mar 09Did Business Growth Power Morphic Holding's (NASDAQ:MORF) Share Price Gain of 126%?
Feb 24How Many Morphic Holding, Inc. (NASDAQ:MORF) Shares Have Insiders Sold, In The Last Year?
Jan 20Morphic Holding (MORF) Presents At 39th Annual Healthcare Conference - Slideshow
Jan 14Companies Like Morphic Holding (NASDAQ:MORF) Can Afford To Invest In Growth
Dec 16Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1 | -250 | -203 | -195 | 7 |
12/31/2025 | 1 | -229 | -191 | -184 | 8 |
12/31/2024 | 0 | -199 | -173 | -176 | 10 |
3/31/2024 | N/A | -161 | -129 | -127 | N/A |
12/31/2023 | 1 | -152 | -114 | -112 | N/A |
9/30/2023 | 7 | -136 | -110 | -109 | N/A |
6/30/2023 | 9 | -130 | -106 | -104 | N/A |
3/31/2023 | 69 | -64 | -105 | -104 | N/A |
12/31/2022 | 71 | -59 | -101 | -101 | N/A |
9/30/2022 | 74 | -56 | -97 | -96 | N/A |
6/30/2022 | 75 | -51 | -97 | -96 | N/A |
3/31/2022 | 19 | -106 | -92 | -91 | N/A |
12/31/2021 | 20 | -96 | -84 | -83 | N/A |
9/30/2021 | 16 | -92 | -78 | -77 | N/A |
6/30/2021 | 39 | -61 | -49 | -49 | N/A |
3/31/2021 | 43 | -50 | -48 | -47 | N/A |
12/31/2020 | 45 | -45 | -47 | -46 | N/A |
9/30/2020 | 39 | -47 | -47 | -46 | N/A |
6/30/2020 | 19 | -61 | -65 | -63 | N/A |
3/31/2020 | 17 | -55 | -63 | -61 | N/A |
12/31/2019 | 17 | -43 | -44 | -42 | N/A |
9/30/2019 | 21 | -29 | 63 | 65 | N/A |
6/30/2019 | 15 | -27 | 72 | 73 | N/A |
3/31/2019 | 9 | -24 | 81 | 82 | N/A |
12/31/2018 | 3 | -24 | 76 | 76 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MORF is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MORF is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MORF is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MORF's revenue (76.5% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: MORF's revenue (76.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MORF is forecast to be unprofitable in 3 years.